Literature DB >> 11302688

Inhibition of cell proliferation by the PCNA-binding region of p21 expressed as a GFP miniprotein.

H Mattock1, D P Lane, E Warbrick.   

Abstract

p21 (WAF1/Cip1) is the only member of the CIP/KIP family which has a well-characterized PCNA-binding domain. p21 is known to have an important function in the coordination of the cellular pathways which are activated in response to DNA damage, though the significance of the p21-PCNA interaction is not completely clear. We have analyzed the effects of expressing a miniprotein containing the PCNA-binding domain of p21 upon the cell cycle and upon the proliferation of various cell types. We have compared this with the effect of expressing a mutant form which is defective in PCNA-binding, but which retains the secondary cyclin-CDK-inhibitory site. No PCNA-dependent effects were seen in the short term upon cell cycle distribution. However, clonogenic assays show that the GFP-peptide miniprotein can significantly suppress proliferation in a PCNA-dependent manner. In some cell types, however, the suppression of proliferation was not PCNA-dependent, suggesting that cellular environment is a contributory factor to the effect of this miniprotein. The capacity of this peptide sequence to suppress cell proliferation in vivo is of interest as the basis for the design of potential antiproliferative therapeutic agents. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11302688     DOI: 10.1006/excr.2001.5160

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  11 in total

Review 1.  Cell penetrating elastin-like polypeptides for therapeutic peptide delivery.

Authors:  Gene L Bidwell; Drazen Raucher
Journal:  Adv Drug Deliv Rev       Date:  2010-05-15       Impact factor: 15.470

2.  Fibroblast growth factor-10 prevents H2O2-induced cell cycle arrest by regulation of G1 cyclins and cyclin dependent kinases.

Authors:  D Upadhyay; W Chang; K Wei; M Gao; G D Rosen
Journal:  FEBS Lett       Date:  2006-12-18       Impact factor: 4.124

3.  Developing peptide-based multivalent antagonists of proliferating cell nuclear antigen and a fluorescence-based PCNA binding assay.

Authors:  William P Bozza; Kun Yang; Jialiang Wang; Zhihao Zhuang
Journal:  Anal Biochem       Date:  2012-04-20       Impact factor: 3.365

4.  Proliferating cell nuclear antigen acts as a cytoplasmic platform controlling human neutrophil survival.

Authors:  Véronique Witko-Sarsat; Julie Mocek; Dikra Bouayad; Nicola Tamassia; Jean-Antoine Ribeil; Céline Candalh; Noélie Davezac; Nathalie Reuter; Luc Mouthon; Olivier Hermine; Magali Pederzoli-Ribeil; Marco A Cassatella
Journal:  J Exp Med       Date:  2010-10-25       Impact factor: 14.307

5.  Inhibition of ovarian cancer cell proliferation by a cell cycle inhibitory peptide fused to a thermally responsive polypeptide carrier.

Authors:  Iqbal Massodi; Shama Moktan; Aruna Rawat; Gene L Bidwell; Drazen Raucher
Journal:  Int J Cancer       Date:  2010-01-15       Impact factor: 7.396

6.  A functional analysis of PCNA-binding peptides derived from protein sequence, interaction screening and rational design.

Authors:  E Warbrick
Journal:  Oncogene       Date:  2006-05-11       Impact factor: 9.867

7.  PCNA dependent cellular activities tolerate dramatic perturbations in PCNA client interactions.

Authors:  Rosemary H C Wilson; Antonio J Biasutto; Lihao Wang; Roman Fischer; Emma L Baple; Andrew H Crosby; Erika J Mancini; Catherine M Green
Journal:  DNA Repair (Amst)       Date:  2016-12-31

8.  Lifespan extension in a semelparous chordate occurs via developmental growth arrest just prior to meiotic entry.

Authors:  Gunasekaran Subramaniam; Coen Campsteijn; Eric M Thompson
Journal:  PLoS One       Date:  2014-04-02       Impact factor: 3.240

9.  PCNA promotes processive DNA end resection by Exo1.

Authors:  Xiaoqing Chen; Sharad C Paudyal; Re-I Chin; Zhongsheng You
Journal:  Nucleic Acids Res       Date:  2013-08-11       Impact factor: 16.971

10.  Cytoplasmic proliferating cell nuclear antigen connects glycolysis and cell survival in acute myeloid leukemia.

Authors:  Delphine Ohayon; Alessia De Chiara; Nicolas Chapuis; Céline Candalh; Julie Mocek; Jean-Antoine Ribeil; Lamya Haddaoui; Norbert Ifrah; Olivier Hermine; Frédéric Bouillaud; Philippe Frachet; Didier Bouscary; Véronique Witko-Sarsat
Journal:  Sci Rep       Date:  2016-10-19       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.